Treace Medical Concepts, Inc. Common Stock (NASDAQ: TMCI) last traded at $4.34, down 2.69% on the session. The quote above updates while this page is open; the figures below are drawn from Treace Medical Concepts, Inc. Common Stock’s own filings and are restated only when a new one is published.
Treace Medical Concepts, Inc. Common Stock trades on NASDAQ under the ticker TMCI. Its market capitalisation is $282.25 million.
Valuation measures for Treace Medical Concepts, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $282.25M |
|---|---|
| Enterprise value | $382.96M |
| Price / sales | 1.37 |
| Price / book | 4.17 |
| Beta | 1.58 |
Trailing-twelve-month figures tagged in Treace Medical Concepts, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $205.31M |
|---|---|
| Net income (TTM) | -$59.52M |
| EPS (TTM) | -$0.920 |
| Gross margin | 79.45% |
| Operating margin | -26.17% |
| Return on equity | -87.86% |
| Cash | $12.61M |
Range and volume for TMCI over the past 52 weeks.
| 52-week high | $7.78 |
|---|---|
| 52-week low | $1.17 |
| Volume | 252.8K |
| Average volume | 689.6K |
| Previous close | $4.46 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.